These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9286331)

  • 21. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
    Sato K; Nagayama H; Takahashi TA
    Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro expansion of CD13+CD33+ dendritic cell precursors from multipotent progenitors is regulated by a discrete fas-mediated apoptotic schedule.
    Santiago-Schwarz F; Borrero M; Tucci J; Palaia T; Carsons SE
    J Leukoc Biol; 1997 Oct; 62(4):493-502. PubMed ID: 9335320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis.
    Kerst JM; Slaper-Cortenbach IC; von dem Borne AE; van der Schoot CE; van Oers RH
    Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors.
    Ferlazzo G; Spaggiari GM; Semino C; Melioli G; Moretta L
    Eur J Immunol; 2000 Mar; 30(3):827-33. PubMed ID: 10741398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway.
    Santiago-Schwarz F; McCarthy M; Tucci J; Carsons SE
    Blood; 1998 Aug; 92(3):745-55. PubMed ID: 9680340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.
    Canque B; Camus S; Yagello M; Gluckman JC
    J Leukoc Biol; 1998 Aug; 64(2):235-44. PubMed ID: 9715264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell factor enhances dendritic cell development.
    Santiago-Schwarz F; Laky K; Carsons SE
    Adv Exp Med Biol; 1995; 378():7-11. PubMed ID: 8526147
    [No Abstract]   [Full Text] [Related]  

  • 31. Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood.
    Saraya K; Reid CD
    Br J Haematol; 1996 May; 93(2):258-64. PubMed ID: 8639414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit.
    De Jong MO; Wagemaker G; Wognum AW
    Blood; 1995 Dec; 86(11):4076-85. PubMed ID: 7492763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
    Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1.
    Lardon F; Snoeck HW; Berneman ZN; Van Tendeloo VF; Nijs G; Lenjou M; Henckaerts E; Boeckxtaens CJ; Vandenabeele P; Kestens LL; Van Bockstaele DR; Vanham GL
    Immunology; 1997 Aug; 91(4):553-9. PubMed ID: 9378494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.
    Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG
    J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.
    Strobl H; Riedl E; Scheinecker C; Bello-Fernandez C; Pickl WF; Rappersberger K; Majdic O; Knapp W
    J Immunol; 1996 Aug; 157(4):1499-507. PubMed ID: 8759731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells.
    Lopez M; Amorim L; Gane P; Cristoph A; Bardinet D; Abina AM; Minty A; Bernard J
    J Immunol Methods; 1997 Oct; 208(2):117-29. PubMed ID: 9433467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-trans-retinoic acid effects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells.
    Douer D; Ramezani L; Parker J; Levine AM
    Leukemia; 2000 May; 14(5):874-81. PubMed ID: 10803520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.